Armata Pharmaceuticals | 10-Q: Quarterly report
Armata Pharmaceuticals | 8-K: Armata Pharmaceuticals Announces First Quarter 2024 Results and Provides Corporate Update
Armata Pharmaceuticals | ARS: Annual Report to Security Holders
Armata Pharmaceuticals | DEF 14A: Definitive information statements
Armata Pharmaceuticals | 8-K: Current report
Armata Pharmaceuticals | 10-K: Annual report
Armata Pharmaceuticals | 8-K: Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2023 Results and Provides Corporate Update
Armata Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director PATTI JOSEPH M
Armata Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Kramer Robin
Armata Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Peterson Todd C.
Armata Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Rychlik Richard
Armata Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Schlesinger Sarah J.
Armata Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Haimovitz Jules
Armata Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Odysseas Kostas D
Armata Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Birx Deborah
Armata Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Innoviva, Inc(85.3%),Innoviva Strategic Opportunities LLC(62.1%)
Armata Pharmaceuticals | 8-K: Current report
Armata Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Armata Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Schlesinger Sarah J.
Armata Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Peterson Todd C.
No Data